Literature DB >> 23775420

Association of bone turnover markers with mortality in women referred to coronary angiography: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.

E Lerchbaum1, V Schwetz, S Pilz, B O Boehm, W März.   

Abstract

UNLABELLED: We examined the association of fatal events with beta-crosslaps (β-CTX) and osteocalcin (OC) concentrations in women. We observed an independent association of β-CTX and OC concentrations with fatal events in women at high to intermediate cardiovascular risk.
INTRODUCTION: There is some evidence suggesting an association of β-CTX and OC with fatal events in men and frail elderly subjects. We aimed to examine the association of fatal events with β-CTX and OC in women.
METHODS: We measured β-CTX and OC in 986 women aged 65 (58-72) years referred to coronary angiography.
RESULTS: Compared to the first β-CTX quartile, the crude hazard ratios (HRs) for all-cause and cardiovascular mortality in the highest β-CTX quartile were 2.50 (1.65-3.81) and 3.28 (1.82-5.91), respectively. In multivariate adjusted models, HRs for all-cause and cardiovascular mortality in the highest β-CTX quartile were 1.72 (1.09-2.70) and 2.31 (1.24-4.32), respectively. The lowest 25-hydroxyvitamin D [25(OH)D] quartile was significantly associated with increased risk of all-cause and cardiovascular mortality in multivariate adjusted models. In those models, the highest β-CTX quartile was associated with an increased risk of all-cause and cardiovascular mortality. For OC concentrations, we found a reverse J-shaped association with noncardiovascular mortality. Using the first quartile as reference, crude and multivariate adjusted HRs for noncardiovascular mortality in the second and third OC quartile were 0.41 (0.19-0.90) [multivariate: 0.40 (0.18-0.88)] and 0.51 (0.25-1.06) [multivariate: 0.43 (0.20-0.94)], respectively. The lowest 25(OH)D quartile was associated with a trend towards increased risk of noncardiovascular mortality in multivariate analysis. In that analysis, OC quartile 2 and 3 were significantly associated with lower risk of noncardiovascular mortality.
CONCLUSIONS: We observed an independent association of high β-CTX with all-cause and cardiovascular mortality and a reverse J-shaped association of OC with noncardiovascular mortality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23775420     DOI: 10.1007/s00198-013-2411-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  29 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Bone mineral density and aortic calcification: the Study of Osteoporotic Fractures.

Authors:  M T Vogt; R San Valentin; K Y Forrest; M C Nevitt; J A Cauley
Journal:  J Am Geriatr Soc       Date:  1997-02       Impact factor: 5.562

Review 3.  Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence.

Authors:  Pawel Pludowski; Michael F Holick; Stefan Pilz; Carol L Wagner; Bruce W Hollis; William B Grant; Yehuda Shoenfeld; Elisabeth Lerchbaum; David J Llewellyn; Katharina Kienreich; Maya Soni
Journal:  Autoimmun Rev       Date:  2013-03-28       Impact factor: 9.754

Review 4.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Authors:  B R Winkelmann; W März; B O Boehm; R Zotz; J Hager; P Hellstern; J Senges
Journal:  Pharmacogenomics       Date:  2001-02       Impact factor: 2.533

5.  High bone turnover is an independent predictor of mortality in the frail elderly.

Authors:  Philip N Sambrook; Charles J S Chen; Lyn March; Ian D Cameron; Robert G Cumming; Stephen R Lord; Judy M Simpson; Markus J Seibel
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

6.  Relationship between serum levels of osteocalcin and atherosclerotic disease in type 2 diabetes.

Authors:  R Reyes-Garcia; P Rozas-Moreno; J J Jimenez-Moleon; M J Lara Villoslada; J A Garcia-Salcedo; S Santana-Morales; M Muñoz-Torres
Journal:  Diabetes Metab       Date:  2011-10-12       Impact factor: 6.041

7.  Increased bone resorption in moderate smokers with low body weight: the Minos study.

Authors:  P Szulc; P Garnero; B Claustrat; F Marchand; F Duboeuf; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography.

Authors:  Stefan Pilz; Winfried März; Britta Wellnitz; Ursula Seelhorst; Astrid Fahrleitner-Pammer; Hans P Dimai; Bernhard O Boehm; Harald Dobnig
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

Review 9.  Testosterone deficiency, insulin resistance and the metabolic syndrome.

Authors:  Michael Zitzmann
Journal:  Nat Rev Endocrinol       Date:  2009-10-27       Impact factor: 43.330

10.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

View more
  6 in total

Review 1.  Multifaceted interaction of bone, muscle, lifestyle interventions and metabolic and cardiovascular disease: role of osteocalcin.

Authors:  I Levinger; T C Brennan-Speranza; A Zulli; L Parker; X Lin; J R Lewis; B B Yeap
Journal:  Osteoporos Int       Date:  2017-03-13       Impact factor: 4.507

2.  Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial.

Authors:  Nicolas Verheyen; Astrid Fahrleitner-Pammer; Evgeny Belyavskiy; Martin R Gruebler; Hans Peter Dimai; Karin Amrein; Klemens Ablasser; Johann Martensen; Cristiana Catena; Elisabeth Pieske-Kraigher; Caterina Colantonio; Jakob Voelkl; Florian Lang; Ioana Alesutan; Andreas Meinitzer; Winfried März; Helmut Brussee; Burkert Pieske; Stefan Pilz; Andreas Tomaschitz
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

3.  Bone Turnover Status: Classification Model and Clinical Implications.

Authors:  Alexander Fisher; Leon Fisher; Wichat Srikusalanukul; Paul N Smith
Journal:  Int J Med Sci       Date:  2018-02-01       Impact factor: 3.738

Review 4.  Nontraditional Cardiovascular Biomarkers and Risk Factors: Rationale and Future Perspectives.

Authors:  Irene Traghella; Francesca Mastorci; Alessia Pepe; Alessandro Pingitore; Cristina Vassalle
Journal:  Biomolecules       Date:  2018-06-15

5.  Bone Turnover Markers Including Undercarboxylated Osteocalcin Are Associated With Mortality Risk in Older Men.

Authors:  Courtney L Robertson; Gaurav Ghosh; Patrick Fitzgerald; Graeme J Hankey; Itamar Levinger; Jonathan Golledge; Osvaldo P Almeida; Leon Flicker; Peter R Ebeling; Bu B Yeap
Journal:  J Bone Miner Res       Date:  2022-07-08       Impact factor: 6.390

Review 6.  Undercarboxylated Osteocalcin: Experimental and Human Evidence for a Role in Glucose Homeostasis and Muscle Regulation of Insulin Sensitivity.

Authors:  Xuzhu Lin; Tara C Brennan-Speranza; Itamar Levinger; Bu B Yeap
Journal:  Nutrients       Date:  2018-06-29       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.